BD Veritor™ System for Rapid Detection of SARS-CoV-2

Time is limited. Results are critical. Staff are busy. Now is when your team needs clear test results, streamlined workflows, efficient documentation and traceability.

The BD Veritor™ Plus System is designed to address these needs in 15 minutes.


Types of COVID-19 Testing

BD is deploying our capabilities, expertise, and scale to address critical health needs related to the coronavirus—from diagnostic offerings which identify COVID-19 to essential medical devices that support patient care. As the global healthcare community searches for effective methods for addressing COVID-19, the role of testing becomes more prominent. There are currently two kinds of tests available: viral tests and antibody tests.


Placeholder

The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.

As you navigate the ever-changing complexities of COVID-19, it is essential to have tools that minimize uncertainty. The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 is engineered to make testing simple and reliable with results available in 15 minutes¹.


Step 1

Collect patient sample

  

Step 2

Remove cap & insert swab into tube

  

Step 3

Mix sample with reagent, then remove swab

  

Step 4

Close dispensing cap, then dispense sample into test device

     

Step 5

Insert test device into the analyzer

For Walk Away mode, insert immediately

For Analyze Now mode, insert after processing sample

 
  1. Step 1
  2. Step 2
  3. Step 3
  4. Step 4
  5. Step 5

BD E-learning Platform Maximizing the capabilities of the BD Veritor™ Plus System

Placeholder

The comprehensive eLearning platform for the BD Veritor™ Plus system streamlines and simplifies training and tracking (local regulation or accreditation efforts), enabling you to quickly train staff and implement point-of-care testing.

Learn more

News & media

Hear from scientist BD leaders

Interview with Dr Patrick R. Murray on C-19 Antigen Tests


READ MORE

Interview with Dr Celine Roger-Dalbert on BD Veritor™ Plus System


READ MORE

 

WHO supports the use of point of care test

WHO guideline

 
 
 

Learn more about Interim guidance for rapid antigen testing for SARS-CoV-2

US CDC guıdelıne

 
 

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK

ECDC TECHNICAL REPORT

 
 
 

Learn more about Interim Guidance on the Use of Rapid Antigen tests for COVID-19 Response

AFRICA CDC GUIDANCE

 

Let's have a conversation

BD
BD